CoViD-19 Nucleic Acid Detection Kit

OaCP informs that the CoViD-19 Nucleic Acid Detection Kit is not a domestic use kit and that the contents of this site are intended exclusively for healthcare professionals.

CoViD-19 Detection Kit


Clinical significance: According to the “New Coronavirus Pneumonia Infection Diagnosis and Treatment Plan” (Trial Version 5) the CoViD 19 nucleic acid test is the gold standard for the diagnosis of suspected patients.

Product Characteristics

Accurate results: the kit contains an internal standard to avoid false negative results and ensure the accuracy of the test result.

Anti-pollution: the principle of “One step” PCR technology reduces reaction time and avoids aerosol pollution.

High sensitivity: the minimum detection baseline is 1000 copies/mL, which ensures the detection of low virus content sample results.

High-throughput: triple PCR reaction system, high detection flux, timely and rapid completion of multiple sample detection.

CE-IVD and CFDA approved.

OaCP and its kit have been listed as certified entities in the Circular of Italy’s Ministry of Health published on 04/03/2020. The document contains updates about indications on diagnostic tests and criteria to follow in the determination of priorities within COVID-19 pandemic.


For any further information or requests please contact us: |

Distributed by:


Distributed in Lebanon, Irak, Jordan, UAE, KSA, Kuwait, Qatar by:

Phoenix House, Monahan Road, T12H1XY Cork (IE)
+353 (0) 212376197
VAT: IE3518703DH
© 2018 OaCP

OaCP Srl
viale G. Fanin 48, 40127 Bologna
Tel. +39 051 637 08 34 / +39 051 021 8095
c.f./p.iva 03616931204 • rea BO 534331 • Cap.Soc. €2000,00 i.v.
Privacy e Cookies